RxSight, Inc. Common Stock
RXST US78349D1072
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-30% | 12% | 215% | -6% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Fountain Tamara |
25.71 USD |
7,000 Sold |
180,002 USD |
12/03/2025 | 12/03/2025 |
Maniar Shweta |
30.87 USD |
3,519 Sold |
108,618 USD |
22/01/2025 | 22/01/2025 |
Corley Jesse Anderson |
31.13 USD |
1,767 Bought |
55,004 USD |
15/01/2025 | 16/01/2025 |
Corley Jesse Anderson |
31.19 USD |
1,443 Bought |
45,000 USD |
15/01/2025 | 15/01/2025 |
Goldshleger Ilya O |
46.08 USD |
3,105 Sold |
143,078 USD |
29/11/2024 | 29/11/2024 |
Goldshleger Ilya O |
45.88 USD |
3,100 Sold |
142,228 USD |
22/11/2024 | 26/11/2024 |
Maniar Shweta |
45.88 USD |
3,782 Sold |
173,518 USD |
26/11/2024 | 26/11/2024 |
Goldshleger Ilya O |
45.00 USD |
3,100 Sold |
139,500 USD |
22/11/2024 | 22/11/2024 |
Goldshleger Ilya O |
45.07 USD |
33 Sold |
1,487 USD |
15/11/2024 | 18/11/2024 |
Goldshleger Ilya O |
45.00 USD |
3,067 Sold |
138,015 USD |
15/11/2024 | 18/11/2024 |